15.363 Strategic Decision Making in the Biomedical Business
Spring 2013
Instructors: Jonathan Fleming, Andrey Zarur
TA: Sheridan Blake
Lecture: T 5:30-8:30 PM (E51-315)
Information:
Announcements
BD Consulting Opportunity and Class Survey
Hi all,Don't forget to evaluate the class (http://web.mit.edu/subjectevaluation/evaluate.html)! It helps us make improvements for the next year.
Also, if anyone is interested in a little more BD and valuation
experience, please contact reilly.glasser@genocea.com regarding the
following opportunity:
Genocea is seeking an intern that can help with the financial and
strategic valuation of our portfolio of products in development
(HSV-2 vaccines). The project would include market opportunity
sizing of the portfolio. The project will also involve evaluating
the strategic positioning of Genocea products within the
competitive landscape as well as profiling current and future
treatment paradigms (comparing them along clinical safety,
efficacy, and tolerability). Taken together, this project would
help Genocea value its portfolio and assess its strategic options.
The intern would be working closely with Genocea's VP of
Business Development.
It was a pleasure working with you all this semester! Have a terrific summer.
Announced on 20 May 2013 3:52 p.m. by Sheridan Blake
Speaker tonight
Wanted to remind you all that we have Ron Zwanziger speaking in tonight's class. Please be on time.Also, you might be interested to know that he started his first
company while still in business school (at Harvard). See below for
his current bio.
Ron Zwanziger has served as Alere's Chairman, Chief Executive
Officer and President since their inception on May 11, 2001. Mr.
Zwanziger served as Chairman, Chief Executive Officer and President
of their predecessor company, Inverness Medical Technology, from
its inception in 1992 through November 2001 when that company was
acquired by Johnson & Johnson. From 1981 to 1991, he was
Chairman and Chief Executive Officer of MediSense, a medical device
company. Mr. Zwanziger served as a director of AMAG
Pharmaceuticals, Inc. from November 2006 to December 2011.
Announced on 14 May 2013 2:18 p.m. by Sheridan Blake
Optional Reading for May 14th
Hi all,I've posted an optional reading to give you more information on our guest speaker (Ron Zwanziger) for our last class. Also, please be sure to be in class on time on Tuesday. It would be rude to interrupt our guest speaker with late entry.
Thank you!
Announced on 09 May 2013 1:50 p.m. by Sheridan Blake
Homework 4
I've posted HW 4 to Stellar. As there isn't as much time to go through this homework and its edging on finals week in your classes, we are not expecting an in-depth analysis akin to expectations for the last couple homeworks and the midterm. We would more like to see your understanding for utilizing decision trees in the decision making process.Announced on 06 May 2013 8:37 p.m. by Sheridan Blake
Homework 3 Update
Hi class,There was a typo in the homework, so an updated version has been uploaded to Stellar this morning. The update concerns the information pertaining to the round B financing (last paragraph on page 4). Please use this version to complete the homework.
Thank you!
Announced on 21 April 2013 11:11 a.m. by Sheridan Blake